Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

More awareness is needed for severe acute respiratory syndrome coronavirus 2019 transmission through exhaled air during non-invasive respiratory support: experience from China

Lili Guan, Luqian Zhou, Jinnong Zhang, Wei Peng, Rongchang Chen
European Respiratory Journal 2020 55: 2000352; DOI: 10.1183/13993003.00352-2020
Lili Guan
1State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
5These authors contributed equally to this work as first authors
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luqian Zhou
1State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
5These authors contributed equally to this work as first authors
6These authors contributed equally to this work as senior authors
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jinnong Zhang
2Dept of Emergency Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
5These authors contributed equally to this work as first authors
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wei Peng
3Division of ICU and Respiratory Service, Dept of Internal Medicine, Salt Lake Regional Medical Center, Heart and Lung Institute of Utah, Salt Lake City, UT, USA
5These authors contributed equally to this work as first authors
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rongchang Chen
1State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
4Dept of Respiratory and Critical Care Medicine, First Affiliated Hospital of Southern University of Science and Technology, Second Clinical Medical College of Jinan University, Shenzhen People's Hospital, Shenzhen Institute of Respiratory Diseases, Shenzhen, China
6These authors contributed equally to this work as senior authors
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: chenrc@vip.163.com
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Non-invasive respiratory support plays an essential role in the treatment of COVID-19. More awareness is needed of viral transmission through exhaled air. http://bit.ly/39kNrrF

To the Editor:

As of 17 February, 2020, China has 70 635 confirmed cases of coronavirus disease 2019 (COVID-19), including 1772 deaths [1]. Human-to-human spread of the virus via respiratory droplets is currently considered to be the main route of transmission. However, exhaled air dispersion during non-invasive respiratory support may increase the risk of coronavirus transmission, and requires more attention from medical personnel and patients.

According to the Chinese Centre for Disease Control and Prevention [2], among 72 314 reported cases in mainland China (44 672 confirmed cases, 16 186 suspected cases, 10 567 clinically diagnosed cases, and 889 asymptomatic infected cases) as of 11 February, 1716 medical staff were infected. Notably, Wang et al. [3] analysed the clinical characteristics of 138 hospitalised cases with COVID-19 and found that the nosocomial infection rate in the study was about 41.3%, with 17 inpatients and 40 medical staff. Given the high use of respiratory support to treat dyspnoea and respiratory failure induced by COVID-19, viral transmission through exhaled air should be considered.

When oxygen is delivered through nasal catheter, mask or non-invasive ventilation (NIV), substantial exhaled air is released into the air, which can increase dispersion of the virus, and subsequently increase the risk of nosocomial infection [4]. Prior studies have suggested that the application of high-flow nasal cannula (HFNC), NIV through the specific mask with optimised vent holes or the helmet with a double-limb circuit may lower the risk of airborne transmission [5, 6]. Performing non-invasive respiratory support in a single, well-ventilated, negative pressure ward is also considered a safe option. Currently, however, the majority of patients are still receiving respiratory support through nasal catheter or common mask in general wards or emergency departments with limited medical resources. The potential for airborne transmission in this population has not received enough attention. Furthermore, a significant proportion of suspected patients with mild to no symptoms who are managing at home may also require long-term home oxygen or NIV treatment (e.g. patients with advanced staged COPD). These patients may increase the risk of family cluster infections by the widespread dispersion of exhaled air in their homes.

Non-invasive respiratory support plays an essential role in the treatment of COVID-19, and more awareness is needed regarding the increased risk of viral transmission from exhaled air. Medical staff should utilise personal protective equipment when providing respiratory support therapy. Patients should wear a medical mask when receiving conventional oxygen therapy or HFNC in order to reduce air dispersion. When performing NIV therapy, because helmet resources are limited and they are not frequently used in routine clinical practice, we suggest avoiding masks with vent holes and adding a filter between the mask and the vent valve to reduce viral transmission. Patient beds should be at least 1 m from one another and the ward air circulation rate needs to be increased [7]. For patients with suspected COVID-19 infection receiving long-term respiratory support at home, it is recommended that they stay in a single, well-ventilated room to avoid potentially infecting their family members.

Shareable PDF

Supplementary Material

This one-page PDF can be shared freely online.

Shareable PDF ERJ-00352-2020.Shareable

Footnotes

  • Conflict of interest: L. Guan has nothing to disclose.

  • Conflict of interest: J. Zhang has nothing to disclose.

  • Conflict of interest: W. Peng has nothing to disclose.

  • Conflict of interest: L. Zhou has nothing to disclose.

  • Conflict of interest: R. Chen has nothing to disclose.

  • Received February 18, 2020.
  • Accepted February 22, 2020.
  • Copyright ©ERS 2020
http://creativecommons.org/licenses/by-nc/4.0/

This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

Reference

  1. ↵
    World Health Organization. Novel Coronavirus (2019-nCoV). Situation Report—28 Feb 17, 2020. www.who.int/docs/default-source/coronaviruse/situation-reports/20200217-sitrep-28-covid-19.pdf?sfvrsn=a19cf2ad_2 Date last updated: 17 February, 2020. Date last accessed: 17 February 2020.
  2. ↵
    The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China] (in Chinese). Zhonghua Liu Xing Bing Xue Za Zhi 2020; 41: 145–151.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Wang D,
    2. Hu B,
    3. Hu C, et al.
    Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020; in press [https://doi.org/10.1001/jama.2020.1585].
  4. ↵
    1. Simonds AK,
    2. Hanak A,
    3. Chatwin M, et al.
    Evaluation of droplet dispersion during non-invasive ventilation, oxygen therapy, nebuliser treatment and chest physiotherapy in clinical practice: implications for management of pandemic influenza and other airborne infections. Health Technol Assess 2010; 14: 131–172. doi:10.3310/hta14460-02
    OpenUrlPubMed
  5. ↵
    1. Hui DS,
    2. Chow BK,
    3. Lo T, et al.
    Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks. Eur Respir J 2019; 53: 1802339. doi:10.1183/13993003.02339-2018
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Hui DS,
    2. Chow BK,
    3. Lo T, et al.
    Exhaled air dispersion during noninvasive ventilation via helmets and a total facemask. Chest 2015; 147: 1336–1343. doi:10.1378/chest.14-1934
    OpenUrl
  7. ↵
    World Health Organization. Infection Prevention and Control during Health Care when Novel Coronavirus (nCoV) Infection is Suspected. www.who.int/publications-detail/infection-prevention-and-control-during-health-care-when-novel-coronavirus-(ncov)-infection-is-suspected-20200125 Date last updated: 25 January, 2020. Date last accessed: 17 February, 2020.
PreviousNext
Back to top
View this article with LENS
Vol 55 Issue 3 Table of Contents
European Respiratory Journal: 55 (3)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
More awareness is needed for severe acute respiratory syndrome coronavirus 2019 transmission through exhaled air during non-invasive respiratory support: experience from China
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
More awareness is needed for severe acute respiratory syndrome coronavirus 2019 transmission through exhaled air during non-invasive respiratory support: experience from China
Lili Guan, Luqian Zhou, Jinnong Zhang, Wei Peng, Rongchang Chen
European Respiratory Journal Mar 2020, 55 (3) 2000352; DOI: 10.1183/13993003.00352-2020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
More awareness is needed for severe acute respiratory syndrome coronavirus 2019 transmission through exhaled air during non-invasive respiratory support: experience from China
Lili Guan, Luqian Zhou, Jinnong Zhang, Wei Peng, Rongchang Chen
European Respiratory Journal Mar 2020, 55 (3) 2000352; DOI: 10.1183/13993003.00352-2020
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Shareable PDF
    • Footnotes
    • Reference
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Agora

  • Airway immune responses to COVID-19 vaccination in COPD patients
  • Wider access to rifapentine-based regimens is needed for TB care globally
  • Screening for PVOD in heterozygous EIF2AK4 variant carriers
Show more Agora

Correspondence

  • Latent COPD: a proposed new term in the disease nomenclature
  • Empiric anti-anaerobic antibiotics are associated with adverse clinical outcomes
  • Anti-anaerobic antibiotics: indication is key
Show more Correspondence

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society